Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue British Journal of Cancer Année : 2008

Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?

Résumé

Gliomas are characterised by local infiltration, migration of tumour cells across long distances and sustained angiogenesis; therefore, proteins involved in these processes are most likely important. Such candidates are semaphorins involved in axon guidance and cell migration. In addition, semaphorins regulate tumour progression and angiogenesis. For cell signalling, class-4 semaphorins bind directly to plexins, whereas class-3 semaphorins require additional neuropilin (NRP) receptors that also bind VEGF(165). The anti-angiogenic activity of class-3 semaphorins can be explained by competition with VEGF(165) for NRP binding. In this study, we analysed the expressions of seven semaphorins of class-3, SEMA4D, VEGF and the NRP1 and NRP2 receptors in 38 adult glial tumours. In these tumours, SEMA3B, SEMA3G and NRP2 expressions were related to prolonged survival. In addition, SEMA3D expression was reduced in high-grade as compared with low-grade gliomas. In contrast, VEGF correlated with higher grade and poor survival. Thus, our data suggest a function for a subset of class-3 semaphorins as inhibitors of tumour progression, and the prognostic value of the VEGF/SEMA3 balance in adult gliomas. Moreover, in multivariate analysis, SEMA3G was found to be the only significant prognostic marker.

Dates et versions

hal-00458867 , version 1 (22-02-2010)

Identifiants

Citer

Lucie Karayan-Tapon, Michel Wager, Joëlle Guilhot, Pierre Levillain, C. Marquant, et al.. Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?. British Journal of Cancer, 2008, 99 (7), pp.1153-1160. ⟨10.1038/sj.bjc.6604641⟩. ⟨hal-00458867⟩
77 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More